ICI therapynivolumabpembrolizumabipilimumabatezolizumabavelumabcemiplimabdurvalumabdostarlimab
…b, and relatlimab/nivolumab. We included cases of SPL following ICI therapy for non-lymphoid malignancies. Duplicated reports, disease prog…
7articles mentioning treatments
12treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: ICI therapy ×
ICI therapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning ICI therapy
7 articles · page 1 of 1ICI therapycheckpoint inhibitionnivolumabsunitinibpembrolizumab
…rich TLS niches.Characterisation of transcriptomic evolution on ICI therapy in ICI-responsive and ICI-resistant primary RCC tumours To unde…
ICI therapynon-small cell lung cancerNSCLCimmune checkpoint inhibitorsBrMICIs
… critical insights into the immune landscape of NSCLC BrM under ICI therapy, highlighting CD4 +PDCD1+CXCR6+ T cells in CSF as a promising b…
combination ICI therapyICI therapyadvanced cancerESCtertiary referral centreImmune checkpoint inhibitorsICIs
…ount for the effect of age, gender, existent heart failure, and combination ICI therapy. Statistical analysis was performed using SPSS.Results 188 pati…
ICI therapymetastatic cancerTriNetX Research Global NetworkCOVID-19
…entified 7,218 adult patients with metastatic cancer initiating ICI therapy. Patients who received COVID-19 mRNA vaccination within 100 day…
ICI therapySteroid treatmentrenal cell carcinomamelanomanon-small cell lung cancerNSIGCcancer
…al cohort of patients with cancer who developed NSIGC following ICI therapy.Methods We retrospectively collected data from 19 institutions …
anti-PD-1 therapyICI therapybladder cancerThe University of North Carolina at Chapel Hillimmune checkpoint inhibitorsICI
…ng A3A. In contrast, A3B expression sensitized BBN963 tumors to anti-PD-1 therapy. Furthermore, we have validated in multiple human datasets that…